Office of Research & Development |
![]() ![]() |
Project Number: | I01BX003651-01A2 |
Title: | Interleukin-33 as an immune therapy for stroke |
Principal Investigator: | Xiaoming Hu |
Location: | Pittsburgh, PA |
Congressional District Code: | 14 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2018 - September 2022 |
FY 2021 Funding Amount: | $201,440 |
Total Award Amount (all years): |
$956,221 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Stroke is one of the major medical concerns for United States military veterans. The classically neurocentric view of the brain in stroke research may have hindered the development of effective therapies. White matter (WM) injury, characterized by loss of myelin and myelin-producing oligodendrocytes (OLs), is a major cause of functional disability after stroke but has not been widely appreciated until recently. Strategies that are able to alleviate both gray matter and WM pathophysiology are nee... |